TELIGEN System Peripheral Motor Nerve Stimulation Indications
K-Number: K223438 · 2023-02-10
Device Summary
Frequently Asked Questions
What is the TELIGEN System Peripheral Motor Nerve Stimulation Indications?
TELIGEN System Peripheral Motor Nerve Stimulation Indications is a medical device that received FDA 510(k) clearance on 2023-02-10. The listed applicant is Medos International SARL. The 510(k) number is K223438.
When did TELIGEN System Peripheral Motor Nerve Stimulation Indications receive FDA 510(k) clearance?
TELIGEN System Peripheral Motor Nerve Stimulation Indications received FDA 510(k) clearance on 2023-02-10, under 510(k) number K223438.
Who is the listed applicant for TELIGEN System Peripheral Motor Nerve Stimulation Indications?
The FDA 510(k) record lists Medos International SARL as the applicant. This does not by itself establish the device manufacturer.
What is the FDA product code for TELIGEN System Peripheral Motor Nerve Stimulation Indications?
The FDA product code for TELIGEN System Peripheral Motor Nerve Stimulation Indications is PDQ.
Related Clinical Trials
Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.
Related PubMed Literature
Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.
Other records listing Medos International SARL as applicant
Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.
Related Devices (Code: PDQ)
Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.
Official Source
View on FDA Database →Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.